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Background: The concept of cenesthopathy was first introduced by Dupré and Camus in 1907 to describe
clinically unexplainable bodily sensations mainly attributed to psychiatric pathology. If it occurs in oral regions, it is
termed oral cenesthopathy and it has been of special interest to psychiatrists and dentists. While there is no
independently defined criteria for this condition, which is classified as either a delusional or a somatoform disorder,
clinical practice and research require a standard scale to measure and rate its symptoms. In this study, we included
any types of psychosomatic symptoms in oral regions as oral dysesthesia, and developed an Oral Dysesthesia
Rating Scale (Oral DRS) and evaluated its validity and reliability as an assessment tool.
Methods: The scale was developed based on literature review and extensive clinical experience. Twelve reviewers
assessed relevancy of each item to oral dysesthesia symptoms by 1–4 scoring scale and item content validity
index was computed. To evaluate the inter-rater reliability of Oral DRS, pairs of raters administered the scale to 40
randomly selected patients with complaints of oral dysesthesia symptoms and Cohen’s weighted kappa coefficient
was determined for each item.
Results: The scale assesses the severity of feelings of foreign body [A1], exudation [A2], squeezing-pulling [A3],
movement [A4], misalignment [A5], pain [A6], and spontaneous thermal sensation or tastes [A7], and the degree of
impairment in eating [B1], articulation [B2], work [B3], and social activities [B4] on a scale of 0–5. Items A1, A2, A3,
A4, B3, and B4 demonstrated acceptable content validity. Inter-rater reliabilities were good or excellent for all
items evaluated.
Conclusion: The Oral DRS can help define the nosography of clinically unexplainable oral dysesthesia through
further case evaluation and clinical research and facilitate devising of treatment modalities.
Keywords: Cenesthopathy, Somatic-type delusional disorder, Somatoform disorder, Delusional parasitosis, Validity,
Reliability, Oral DRSBackground
Clinically unexplainable somatic symptoms occurring in
patients mainly suffering from psychotic disorders, which
is termed “cenesthopathy,” was first described by Dupré
and Camus in 1907 [1,2]. In the history of Japanese medi-
cine, which has been largely influenced by French and
German medicine, the concept of cenesthopathy was
introduced by Hozaki [3]. He reported cases of patients
complaining of chronic unusual sensations especially in* Correspondence: tnis.psyc@tmd.ac.jp
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unless otherwise stated.oral regions and designated it as “oral cenesthopathy”. Its
nosography has been discussed in case reports and re-
views in contemporary Japanese psychiatry [4-12], but
overlooked in mainstream medicine. According to the
University Psychiatry Clinic in Japan [5], 18 out of 10,278
outpatient cases (0.175%) seen in 5.5 years were diagnosed
as oral cenesthopathy. Patient complaints included un-
usual and uncomfortable sensations in the mouth such as
over-secretion of mucus, tingling, burning, pain, pulling
on the teeth, moving teeth, foreign bodies, and unusual
tastes without a somatic base. While infrequent, this con-
dition desires clinical attention because patients usually
visit multiple physicians and dentists seeking treatment. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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symptoms.
The diagnosis of oral cenesthopathy is still controver-
sial, and contemporary psychiatry does not provide inde-
pendently defined diagnostic criteria. Hozaki suggested
that cenesthopathy occurring alone should be differenti-
ated from that showing comorbidity with other psychotic,
mood, or organic brain disorders [13]. In our clinical
experience, abnormal somatic sensations that are unex-
plainable and delusional tend to be considered classical
cenesthopathy. For example, if a patient complains “a wire
comes out of my gum and coils around my teeth”, this
condition is categorized as a delusional disorder, somatic
type (297.1) in the Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition (DSM-IV), and as a de-
lusional disorder (F22.0) in the ICD-10 Classification of
Mental and Behavioural Disorders (ICD-10). However, a
complain like “something sticky is always in my mouth
and annoys me” is not absurd but does indicate a patho-
logical condition. A patient with such a complain will be
categorized to have a somatoform disorder. Commonly
described “burning mouth syndrome” is categorized as a
pain disorder (307.8 in DSM-IV and F45.4 in ICD-10).
Here in this paper, to include any types of psychosomatic
symptoms in oral regions with psychotic or somatoform
features as well as comorbidities with other mental illness,
abnormal oral sensations are consistently referred to as
“oral dysesthesia”.
Regardless of diagnostic taxonomy, reports of cases
with abnormal oral sensations have accumulated over
the years. There has been much discussion about treat-
ment modalities [7,8,10,14-16] and potential biomarkers
such as altered cerebral blood flow [9]. Descriptions of
symptom characteristics and severities are subjective and
limited by individual bias. Therefore, a standardized symp-
tom assessment tool is necessary to facilitate scientific dis-
cussion among health care providers and researchers for
identifying biomarkers and improving diagnosis and treat-
ment modalities. Currently, there are no standard tools to
measure and rate oral dysesthesia symptoms. In this study,
we developed the Oral Dysesthesia Rating Scale (Oral
DRS) and evaluated its validity as an assessment tool. We
also evaluated its reliability by utilizing it in patients com-
plaining of oral dysesthesia symptoms. Since patients
often develop impairments in oral functions such as eating
and speaking as well as in performance of daily activities,
this new tool is designed to also assess these dysfunctions.
Methods
Development of Oral DRS
The Tokyo Medical and Dental University Oral DRS was
developed based on literature review and extensive clinical
experience. The literature included various case reports
and a case–control study on oral dysesthesia [7,9,14-16],which provided information on the nature and diversity of
symptoms as well as the influence on oral and daily
functions. Oral DRS consists of a Symptom Severity Scale
(SSS) [A], Functional Impairment Scale (FIS) [B], and
Visual Analog Scale (VAS) [C] (Additional file 1). In the
SSS [A], oral symptoms are classified into seven categories:
feelings of foreign body [A1], exudation [A2], squeezing-
pulling [A3], movement [A4], misalignment [A5], pain
[A6], and spontaneous thermal sensation or tastes [A7].
The FIS [B] assesses the degree of impairment of eating
[B1], articulation [B2], work [B3], and social activities [B4].
For each category, interviewers are required to identify
symptoms or impairment and assess their severity in a
semi-structured manner. For example, in the assessment of
[A1], the interviewers start with leading questions “Do you
feel something foreign is stuck in your mouth?” If the an-
swer is yes, the interviewers rate its severity on a scale of
0–5 (0: none, 1: subtle or suspected, 2: mild, 3: moderate,
4: severe, 5: extremely severe); each severity level is ex-
plained in the scoring sheet to aid assessment. The VAS
[C] consist of two scales that assess overall subjective se-
verity of the symptoms [C1] and changes in severity of the
symptoms [C2]. Each VAS is 100-mm long, where 0 mm is
“No symptoms” and 100 mm is “Extremely severe” for
[C1], and 0 mm is “Worse”, 50 mm is “no change”, and
100 mm is “Better” for [C2]. Patients are instructed to
mark on the VAS sheet with a pen. The Oral DRS is avail-
able in Japanese and English with the respective instruction
manuals on our website: (http://www.tmd.ac.jp/med/psyc/
research/oral-drs.html). The validity and reliability of the
Japanese version was assessed in this study.
Content validity
Twelve reviewers assessed the content validity of Oral
DRS to ensure that the included items are relevant to
the purpose of the tool. Reviewers include eight psychia-
trists and four dentists from our university hospital who
had encountered oral dysesthesia in their practice but
were not involved in the development of this tool. The re-
viewers were requested to evaluate each of the 11 items in
the scales [A] and [B] on the score sheet as “1 = not
relevant, 2 = somewhat relevant, 3 = quite relevant, or
4 = highly relevant”. Item content validity index (I-CVI)
for each item was computed as the number of reviewers
giving a rating of either 3 or 4, divided by the total number
of reviewers [17]. An acceptable I-CVI is defined as 0.8 or
above, while an average of 0.90 or above indicates excel-
lent content validity [18]. Reviewers were also asked to
choose one of the three statements regarding sufficiency
of items for oral dysesthesia symptoms: 1. There are items
that need to be added to the scales, 2. There are items that
need to be omitted from the scales, 3. Items in the scales
are necessary and sufficient. The reviewers were invited to
provide feedback under a heading “any comments”.
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To evaluate the inter-rater reliability of Oral DRS, Oral
DRS was utilized in 40 randomly selected patients who
consulted the psychiatry clinic or psychosomatic dentistry
clinic of the university hospital with complaints of oral
dysesthesia symptoms. All the patients had been assessed
by dentists and their symptoms were not regarded as
organic or functional in origin. The raters consisted of
psychiatrists or dentists who were instructed on how to
perform semi-structured interviews using a written man-
ual. Pairs of raters were formed, and each individual in the
pair administered Oral DRS to the same patient separ-
ately on the same day. The first raters from the pair
assessed patients using all three scales, while the second
interviewers used [A] and [B] but omitted [C]. Cohen’s
weighted kappa coefficient [19,20] was determined for
each item in scales [A] and [B] in order to evaluate the
inter-rater reliability for the tool. The R software
(Vienna, Austria) version 2.13.0 with “psych” package was
used for this analyses. Kappa agreement was defined a
priori as excellent (kappa coefficient ≥ 0.8), good (≥0.6),
moderate (≥0.4), fair (≥0.2), or poor (<0.2) [21]. This study
was conducted with the approval of the Ethical Commit-
tee of Tokyo Medical and Dental University (No. 23–21,
No. 356) and all participants gave written informed con-
sent in accordance with the committee’s guidelines.
Results
Content validity
All reviewers completed the score sheet. I-CVI for each
item of Oral DRS is shown in Figure 1. For the SSS [A],
items A1 (foreign body), A2 (exudation), A3 (squeezing-
pulling), and A4 (movement) demonstrated acceptable
content validity (≥0.8) (1.00, 1.00, 0.92 and 0.83,
respectively), while items A5 (misalignment), A6 (pain),
and A7 (spontaneous thermal sensation or tastes) did not
reach acceptable values (0.50, 0.50 and 0.58, respectively).Figure 1 Item content validity index for scales [A] and [B]. Item conten
Scale [A], items A1, A2, A3, and A4 demonstrated acceptable content valid
For the Functional Impairment Scale [B], while items B1 and B2 did not rea
content validity.For the FIS [B], items B3 (work) and B4 (social activities)
demonstrated acceptable content validity (0.92 and 0.83,
respectively), but items B1 (eating) and B2 (articulation)
did not reach acceptable values (0.75 and 0.67, respect-
ively). None of the reviewers chose “1 = not relevant” for
any item in the scales. For the question regarding suffi-
ciency of items, three reviewers chose “1. There are
items that need to be added to the scales” and commen-
ted that “feeling of dry mouth”, “suicidal ideation”, and
“depersonalization” should be considered for the assess-
ment. All other reviewers chose “3. Items in the scales
are necessary and sufficient” and added no comments.
Inter-rater reliability
A total of 40 patients (8 men and 32 women) gave con-
sent for the study and were assessed by Oral DRS. The
demographics of the patients are shown in Table 1. The
mean age of the subjects was 65.5 ± 10.0 (mean ± stand-
ard deviation) years. Duration of the illness at the time
of the evaluation was 5.5 ± 3.9 years. The primary diag-
noses were major depressive disorders for 13 patients,
bipolar disorder for one patient, schizophrenia for one
patient, and somatic-type delusional disorder for one pa-
tient. The remaining 24 patients were diagnosed with
somatoform disorders.
To overview the frequency distribution of the symp-
toms, the cumulative number of patients who were rated
as “2: mild” or greater for each item in scales [A] and [B]
are shown in Figure 2. The symptoms as in items A1
and A2 were relatively frequent, followed by items A3,
A5 and A6, while the symptoms as in items A4 and A7
were relatively less frequent. The functional impairments
as in items B4 was most frequent, followed by B3, B2
and B1 in descending order.
Cohen’s weighted kappa coefficients were calculated
for each item in the [A] and [B] scales (Table 2). For the
SSS [A], agreements between two raters, as defined byt validity indices for all items are shown. For the Symptom Severity
ity (≥0.8), while items A5, A6, and A7 did not reach acceptable values.
ch acceptable values, items B3 and B4 demonstrated acceptable
Table 1 Demographics
Age (years) 65.5 ± 10.0a
Duration of illness (years) 5.5 ± 3.9a
Sex (male : female) 8 : 32
Primary diagnosis
Somatoform disorders 24
Major depressive disorder 13
Bipolar disorder 1
Schizophrenia 1





Anxiolitics and hypnotics 23
aaverage ± standard deviation. bcumulative number of patients on
each medication.
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(0.95), A2 (0.89), A3 (0.90), A4 (0.88), A5 (0.96) and A6
(0.83) and good (≥0.6) for item A7 (0.70). For the FIS
[B], agreements between two raters were excellent for
items B1 (0.87), B3 (0.93) and B4 (0.80) and good for
item B2 (0.65).Discussion
We developed a novel assessment tool to quantitatively
evaluate psychosomatic symptoms in oral regions and
the consequent functional impairments. We also assessed
its content validity and inter-rater reliability. Patients with
oral dysesthesia experience unusual sensations and report
their symptoms using various descriptions. We includedFigure 2 Frequency distribution of the symptoms. To overview the freq
patients who were rated as “2: mild” or more for each item in scales [A] an
pattern of I-CVI except for items A4 and A7 whose values are relatively lowmultiple sensations in the SSS [A] after categorizing the
nature of the reported symptoms.
Most reviewers felt items in the scales are necessary
and sufficient. However, not all items in the scales dem-
onstrated adequate content validity. It is possible that
the reviewers feel symptoms or impairments are more
relevant to the scales if they are encountered more fre-
quently, and vice versa. Comparing Figure 1 (I-CVI) and
Figure 2 (frequency distribution of the symptoms) helps
to overview this tendency, where the first three items in
the scale [A] and the last two items in the scale [B] are
relatively frequent and regarded as more relevant. The
item A4 (movement) demonstrated high I-CVI, while its
frequency was relatively low. This discrepancy might be
due to the bizarreness of the moving sensation as a
symptom to the interviewers. That is, since moving sen-
sation remind the interviews of delusional infestation
[22], they may consider it is adequately relevant to the
scale even though it is clinically rare. With regard to less
frequent symptoms such as “salty taste in the mouth”
[A7], some of the reviewers may have never encountered
patients with these symptoms, yet these symptoms may
be the only and most important concern of the patient.
Therefore, we believe that the items with low I-CVI
should be retained in the scales in order not to miss rare
symptoms. Some reviewers commented that feeling of dry
mouth, suicidal ideation, and depersonalization should be
included in the scales. However, feeling of dry mouth was
not included since it is a common medical complaint and
not necessarily presented as dysesthesia. We may consider
including it in a future revision if more users of the
current tool demand it. One reviewer recommended the
inclusion of suicidal ideation in the scale since oral
dysesthesia is so uncomfortable in some patients that they
feel suicidal. Therefore, the risk of suicide needs to be
carefully evaluated for patients with oral dysesthesia, butuency distribution of the symptoms, the cumulative number of
d [B] is shown. The distribution pattern tends to be similar to the
compared to those of I-CVI (Figure 1).
Table 2 Kappa coefficients










B4. Social activities 0.80
Kappa coefficient were good (≥0.6) for items A7 and B2. For all other items,
agreements were excellent (≥0.8).
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Rating Scale (HDRS) [23] can be simultaneously used with
the Oral DRS for this purpose. It is important to note that
a reviewer recommended including depersonalization in
the scale, since some patients complain of this symptom
along with abnormal oral sensations. Although cen-
esthopathy is considered to be associated with a state of
depersonalization as discussed in a recent review article
[2], we did not include it in the scale because it is not a
direct representation of oral dysesthesia; instead, we
recommend that it be noted in the margin of the scor-
ing sheet.
Overall, the inter-rater reliability, as evaluated using
Cohen’s kappa coefficients, was good, and we conclude
that our tool is reliable for assessing symptoms of oral
dysesthesia and the consequent functional impairments.
The demographics of the patients included in this study
provide an additional overview of typical characteristics
of patients with oral dysesthesia as they were randomly
recruited from our daily practice. Based on our clinical
experience, a typical patient may be an elderly woman
having this condition for relatively a long time with a
history of anxiolytics, antidepressants, and/or antipsy-
chotics use.Conclusion
Oral DRS is a reliable tool to quantitatively evaluate
symptoms of oral dysesthesia and the consequent func-
tional impairments. It is designed to cover various symp-
toms presented by patients by classifying them into
seven main categories. In addition to being applied for
clinical evaluation and follow-up, this tool can be uti-
lized for clinical research on topics such as elucidating
the association between severity of each symptom and
findings of imaging studies.Additional file
Additional file 1: Oral Dysesthesia Rating Scale. http://www.tmd.ac.
jp/med/psyc/research/oral-drs.html.
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